Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria.

The in vitro activities of a new quinolone, WIN 57273, and the combination of piperacillin and tazobactam, a beta-lactamase inhibitor, were compared with those of cefoxitin, ceftizoxime, chloramphenicol, clindamycin, imipenem, metronidazole, and piperacillin for 123 clinical anaerobic isolates. Ceft...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Venezia, R A, Yocum, D M, Robbiano, E M, Echols, R M
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1990
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171949/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2178340/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.9.1858
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!